Sharemaestro company-news research for Sophia Genetics SA (SOPH), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NASDAQ
United States
Insufficient evidence
Company news sentiment
SOPH news sentiment
Sophia Genetics SA
Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.
Weighted tone50Neutral is 50
No current sentiment signal
0/100 evidence confidence
0% direct company focus
0 current stories across 0 publishers
Current company news
The current company-level signal is not yet measurable
Available headlines do not meet the required combination of freshness, direct relevance and independent source depth. The neutral score is a withheld classification, not a neutral forecast.
Available context
+36.0% over one week, +36.5% over four weeks, trend active, and materially above fair value.
Why classification is withheld
No current company-specific story carries enough weight to establish a direct signal.
Evidence confidence is 0/100, below the threshold for a firm classification.
50/100
Weighted toneNo current sentiment signal
0/100
Evidence confidencethin evidence
0%/100
Company focus0 direct stories
N/A/100
Evidence agreementrequires at least 2 stories
News history
Tone and story flow over 21 days
No measurable trajectory yet
The chart will begin when a dated headline passes the relevance and freshness controls.
Evidence confidence
What supports the score
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Sample depth0
0 effective storiesSource breadth0
0 independent publishersDirect relevance0
company-specific evidence shareFreshness0
recency-weighted evidenceAgreement0
requires at least 2 storiesSource independence0
lower publisher concentrationPrice context
Sentiment against the 26-week price path
No sufficiently fresh, directly relevant company news is available for a price comparison.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
Insufficient evidence
News subjects
What is shaping the score
Catalyst structure will appear as classified company evidence builds.
Source mix
Where the evidence comes from
No current publisher evidence is available.
Recurring subjects
Subjects appearing most often
Topic structure will appear when classified tags are present in the current feed.
Earlier readings
How the score has changed
ConstructiveBalanced or withheldCautious
Source headlines
The news behind the score
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
No qualifying current company evidence
No sufficiently fresh and relevant headline currently passes the evidence rules. Earlier readings remain in the timeline and are not relabelled as a neutral current outlook.
Earlier company news
SOPH news archive
Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above.
Aug
01
2026
TradingKeyArchivedNeutral tone
Sophia Genetics SA (SOPH) Financial Health: Profitability & Balance Sheet Analysis
- Published
- 1 Aug 2026 00:59
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
28
2026
TradingKeyArchivedNeutral tone
Sophia Genetics SA (SOPH) Shareholder Structure: Major Shareholders & Institutional Holdings
- Published
- 28 Jul 2026 05:28
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
23
2026
MT NewswiresArchivedNeutral tone
Sophia Genetics Insider Sold Shares Worth $286,099, According to a Recent SEC Filing
- Published
- 23 Jul 2026 08:48
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
22
2026
MarketBeatArchivedNeutral tone
HC Wainwright Estimates SOPHiA GENETICS Q2 Earnings
- Published
- 22 Jul 2026 14:04
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
22
2026
Stock TitanArchivedNeutral tone
SOPHiA GENETICS (SOPH) affiliate files to sell 37,000 founders shares on NASDAQ
- Published
- 22 Jul 2026 01:03
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
21
2026
Stock TitanArchivedNeutral tone
SOPHiA GENETICS sets 8 a.m. webcast for Q2 results call
- Published
- 21 Jul 2026 18:28
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
20
2026
MarketBeatArchivedNeutral tone
HC Wainwright Initiates Coverage on SOPHiA GENETICS (NASDAQ:SOPH)
- Published
- 20 Jul 2026 14:04
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
19
2026
MSNArchivedNeutral tone
SOPHiA GENETICS prices $50M public offering at $4.75 per share
- Published
- 19 Jul 2026 03:06
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
17
2026
GuruFocusArchivedNeutral tone
Insider Sell: Philippe Menu Sells 5,000 Shares of Sophia Genetics SA
- Published
- 17 Jul 2026 19:06
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
09
2026
MarketBeatArchivedNeutral tone
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells $93,376.80 in Stock
- Published
- 9 Jul 2026 08:10
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
08
2026
MarketBeatArchivedNeutral tone
SOPHiA GENETICS (NASDAQ:SOPH) CEO Ross Muken Sells 9,838 Shares
- Published
- 8 Jul 2026 13:57
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
04
2026
MT NewswiresArchivedNeutral tone
Sophia Genetics Insider Sold Shares Worth $506,690, According to a Recent SEC Filing
- Published
- 4 Jul 2026 19:48
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
01
2026
Stock TitanArchivedNeutral tone
SOPH (NASDAQ) affiliate sells via 10b5-1; 50,069-share trade listed
- Published
- 1 Jul 2026 01:21
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
30
2026
MarketBeatArchivedNeutral tone
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) CEO Sells $290,400.20 in Stock
- Published
- 30 Jun 2026 05:27
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
28
2026
TradingViewArchivedNeutral tone
Enterprise value to EBIT forward of SOPHiA GENETICS SA – NASDAQ:SOPH
- Published
- 28 Jun 2026 15:14
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
28
2026
TradingViewArchivedNeutral tone
Enterprise value to EBITDA forward of SOPHiA GENETICS SA – NASDAQ:SOPH
- Published
- 28 Jun 2026 09:38
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
27
2026
MarketBeatArchivedNeutral tone
SOPHiA GENETICS (NASDAQ:SOPH) Insider Philippe Menu Sells 5,000 Shares of Stock
- Published
- 27 Jun 2026 05:23
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
26
2026
Investing.com CanadaArchivedNeutral tone
Form 144 SOPHIA GENETICS SA For: 25 June By Investing.com
- Published
- 26 Jun 2026 11:22
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
25
2026
Stock TitanArchivedNeutral tone
SOPHiA GENETICS (SOPH) president sells 422 shares to cover RSU taxes
- Published
- 25 Jun 2026 14:04
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
23
2026
Insider MonkeyArchivedNeutral tone
Is SOPHiA GENETICS SA (SOPH) Among the Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On?
- Published
- 23 Jun 2026 21:03
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
23
2026
Investing.com South AfricaArchivedNeutral tone
Form 144 SOPHIA GENETICS SA For: 22 June By Investing.com
- Published
- 23 Jun 2026 18:23
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
23
2026
Stock TitanArchivedNeutral tone
SOPH (NASDAQ: SOPH) affiliate notifies sale of 774 RSU shares, recent 10b5-1 trades listed
- Published
- 23 Jun 2026 06:48
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
22
2026
Stock TitanArchivedNeutral tone
Director Troy Cox receives new SOPHiA GENETICS (SOPH) RSU and option grants
- Published
- 22 Jun 2026 21:13
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
22
2026
Stock TitanArchivedNeutral tone
[6-K] SOPHiA GENETICS SA Current Report (Foreign Issuer) | SOPH SEC Filing - Form 6-K
- Published
- 22 Jun 2026 19:17
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
22
2026
FidelityArchivedNeutral tone
SOPHiA GENETICS Announces Closing of $57.5 Million Public Offering of Ordinary Shares With Full Exercise of the Underwriters' Option to Purchase Additional Shares
- Published
- 22 Jun 2026 12:49
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.